Volume 21, Number 9—September 2015
THEME ISSUE
Emerging Infections Program
Emerging Infections Program
Tracking Pertussis and Evaluating Control Measures through Enhanced Pertussis Surveillance, Emerging Infections Program, United States
Tami H. Skoff
, Joan Baumbach, and Paul R. Cieslak
, Joan Baumbach, and Paul R. Cieslak
Table
Completeness of pertussis surveillance data collected from the NNDSS and EPS, United States, 2011–2012*
| Characteristic | Complete, %† |
Difference, % | |
|---|---|---|---|
| NNDSS‡ | EPS | ||
| Race | 76 | 91 | 15 |
| Ethnicity | 72 | 93 | 11 |
| Any cough | 79 | 100 | 21 |
| Paroxysms | 78 | 100 | 22 |
| Whoop | 74 | 97 | 23 |
| Post-tussive vomiting | 75 | 99 | 24 |
| Primary symptoms known§ | 72 | 96 | 24 |
| Cough onset date | 66 | 100 | 34 |
| Duration of cough | 71 | 100 | 29 |
| Hospitalized | 73 | 99 | 26 |
| ≥1 vaccine date and type, age range 3 mo–7 y | 71 | 99 | 28 |
*Data were obtained from Kamiya et al. (7). NNDSS, National Notifiable Disease Surveillance System; EPS, Enhanced Pertussis Surveillance. All p values for comparisons were <0.0001.
†Unknown or missing responses were considered incomplete.
‡NNDSS completeness calculation excludes data from EPS area.
§Cough, paroxysms, whoop, and post-tussive vomiting
Page created: August 12, 2015
Page updated: August 12, 2015
Page reviewed: August 12, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.